ONTOLOGY REPORT - ANNOTATIONS
| Term: | (3,4-dihydroxyphenyl)acetic acid |
|
| Accession: | CHEBI:41941
|
browse the term
|
| Definition: | A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. |
| Synonyms: | related_synonym: | 2-(3,4-DIHYDROXYPHENYL)ACETIC ACID; 3,4-Dihydroxyphenylacetic acid; C8H8O4; InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12); InChIKey=CFFZDZCDUFSOFZ-UHFFFAOYSA-N; OC(=O)Cc1ccc(O)c(O)c1; dopacetic acid; homoprotocatechuic acid |
| | alt_id: | CHEBI:1386; CHEBI:41936 |
| | xref_casrn: | 102-32-9 |
| | xref: | Beilstein:2211017 "Beilstein Registry Number"; ChEMBL:351292 "ChEMBL COMPOUND"; ChemIDplus:102-32-9 "CAS Registry Number"; CiteXplore:11251641 "PubMed citation"; CiteXplore:11681538 "PubMed citation"; CiteXplore:11868042 "PubMed citation"; CiteXplore:15212971 "PubMed citation"; CiteXplore:15862791 "PubMed citation"; CiteXplore:18706927 "PubMed citation"; CiteXplore:19191673 "PubMed citation"; CiteXplore:22770225 "PubMed citation"; CiteXplore:4420192 "PubMed citation"; DrugBank:DB01702 "DrugBank"; Gmelin:874810 "Gmelin Registry Number"; HMDB:HMDB01336 "HMDB"; KEGG COMPOUND:102-32-9 "CAS Registry Number"; KEGG COMPOUND:C01161 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D015102 |
| | xref: | NIST Chemistry WebBook:102-32-9 "CAS Registry Number"; PDBeChem:DHY "PDBeChem"; Reaxys:2211017 "Reaxys Registry Number"; Wikipedia:DOPAC "Wikipedia" |
| | cyclic_relationship: | is_conjugate_acid_of CHEBI:17612 |
|
|
(3,4-dihydroxyphenyl)acetic acid
|
| G |
Actb |
actin, beta |
|
affects binding |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
multiple interactions |
EXP |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
increases abundance |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases methylation |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
increases methylation |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
multiple interactions |
EXP |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
increases abundance |
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
EXP |
1 |
211,269,366 |
211,287,596 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases abundance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
Term paths to the root
|